Results 191 to 200 of about 2,895,252 (212)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Integrating DNA Methylation Measures of Biological Aging into Social Determinants of Health Research
Current Environmental Health Reports, 2022Daniel W Belsky, Laurel Raffington
exaly
Stress-induced biological aging: A review and guide for research priorities
Brain, Behavior, and Immunity, 2022Judith E Carroll, Kelly E Rentscher
exaly
Quantification of biological aging in young adults
Proceedings of the National Academy of Sciences of the United States of America, 2015Daniel W Belsky +2 more
exaly
Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
Biomedicines, 2020Stanislav Rybtsov, Alexander Kagansky
exaly